These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34505138)

  • 1. Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients.
    Wang H; Zhang J; Lu Z; Dai W; Ma C; Xiang Y; Zhang Y
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34505138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS
    Zhang ZJ; Wu WY; Hou JJ; Zhang LL; Li FF; Gao L; Wu XD; Shi JY; Zhang R; Long HL; Lei M; Wu WY; Guo DA; Chen KX; Hofmann LA; Ci ZH
    J Integr Med; 2020 May; 18(3):229-241. PubMed ID: 32307268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
    Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
    J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking.
    Tianyu Z; Liying G
    Bioengineered; 2021 Dec; 12(1):2274-2287. PubMed ID: 34077310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform.
    Hwang W; Han N
    Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
    Gao LQ; Xu J; Chen SD
    Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19).
    Yang BY; Wang HZ; Ma ZZ; Lu C; Li Y; Lu ZY; Lu XL; Gao B
    Curr Med Sci; 2021 Apr; 41(2):297-305. PubMed ID: 33877545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
    Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
    Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
    Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
    J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19).
    Huang F; Li Y; Leung EL; Liu X; Liu K; Wang Q; Lan Y; Li X; Yu H; Cui L; Luo H; Luo L
    Pharmacol Res; 2020 Aug; 158():104929. PubMed ID: 32442720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on drug repurposing applicable to COVID-19.
    Dotolo S; Marabotti A; Facchiano A; Tagliaferri R
    Brief Bioinform; 2021 Mar; 22(2):726-741. PubMed ID: 33147623
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking.
    K C M; K A AN
    Comb Chem High Throughput Screen; 2022; 25(12):2089-2102. PubMed ID: 35142268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors.
    Kumawat A; Namsani S; Pramanik D; Roy S; Singh JK
    J Biomol Struct Dyn; 2022; 40(20):9897-9908. PubMed ID: 34155961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing against SARS-CoV-2 using computational approaches.
    Kumar S; Kovalenko S; Bhardwaj S; Sethi A; Gorobets NY; Desenko SM; Poonam ; Rathi B
    Drug Discov Today; 2022 Jul; 27(7):2015-2027. PubMed ID: 35151891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
    Wang S; Sun Q; Xu Y; Pei J; Lai L
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
    Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
    Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis.
    Li H; Li Y; Luo C; Liang X; Liu Z; Liu Y; Ling Y
    Comput Math Methods Med; 2022; 2022():9604456. PubMed ID: 35237344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.